Accuray (ARAY) Cash from Operations Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Accuray | 47,295.88 | -38.49 Mn | 25.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.80% |
| Dec 31, 2025 | -23.12% |
| Sep 30, 2025 | 44.24% |
| Mar 31, 2025 | 24.88% |
| Dec 31, 2024 | -35.75% |
| Sep 30, 2024 | 21.60% |
| Mar 31, 2024 | -25.03% |
| Dec 31, 2023 | 18.04% |
| Sep 30, 2023 | 13.58% |
| Mar 31, 2023 | 9.73% |
| Dec 31, 2022 | -90.77% |
| Sep 30, 2022 | 14.91% |
| Mar 31, 2022 | 16.86% |
| Dec 31, 2021 | 57.39% |
| Sep 30, 2021 | -4.92% |
| Mar 31, 2021 | 40.72% |
| Dec 31, 2020 | 19.17% |
| Sep 30, 2020 | -17.44% |
| Jun 30, 2020 | 65.51% |
| Mar 31, 2020 | -102.12% |
| Dec 31, 2019 | 56.84% |
| Sep 30, 2019 | -10.84% |
| Jun 30, 2019 | 83.17% |
| Mar 31, 2019 | -20.29% |
| Dec 31, 2018 | -52.76% |
| Sep 30, 2018 | -9.63% |
| Jun 30, 2018 | 53.72% |
| Mar 31, 2018 | 17.16% |
| Dec 31, 2017 | 52.23% |
| Sep 30, 2017 | 0.21% |
| Jun 30, 2017 | 44.10% |
| Mar 31, 2017 | -33.37% |
| Dec 31, 2016 | -19.04% |
| Sep 30, 2016 | 32.79% |
| Jun 30, 2016 | -1.60% |
| Mar 31, 2016 | 0.25% |
| Dec 31, 2015 | -5.17% |
| Sep 30, 2015 | 26.16% |